- 首頁
- 客製化服務
- Drug screening
- AI-driven drug discovery (AIDD)
- AI-driven drug discovery (AIDD)
AI-driven drug discovery (AIDD)
siRNA synthesis/miRNA synthesis/shRNA synthesis
Molecular docking-based virtual screening
AI-driven drug discovery (AIDD)
Customized Mouse Monoclonal Antibody
Customized Rabbit Monoclonal Antibody
Customized Polyclonal Antibody
Single B Cell Screening platform
Fully Human Antibody Discovery Platform
Anti-Idiotype Antibody discovery
De novo Antibody Protein Sequencing(MASS based)
HTP recombinant Antibody production
Bispecific antibody production
RushMab™ - Small Scale Antibody Expression Packages
Afucosylated Antibody Expression Platform
Antibody drug conjugations service
Antibody Developability Assessment
Affinity Measurment (Biacore-SPR assay)
CRISPR Point Mutation cell line
Commercial License for CHOK1BN cell line
qPCR primer set-即時定量聚合酶連鎖反應引子組
Next generation sequencing (NGS)-次世代定序
NTA analysis (Nanoparticle Tracking Analysis)-奈米顆粒追踪分析
AI-driven drug discovery (AIDD)
AI-driven drug discovery (AIDD)AI-driven drug discovery (AIDD)
編號:
Drug screening、AI-driven drug discovery、Virtual screening
原價:
特價:
數量/
一、服務介紹
AI-driven的超高通量虛擬篩選,原廠利用自行開發的平台-PLANET (Protein-ligand affinity prediction NETwork) 作為深度學習模式 (Deep learning model),可進行數千萬到90億個化合物分析。較大的化合物庫可提供更多樣化的化學結構,從而增加找到與特定靶點具有親和力的化合物之可能性,在AI平台篩選後,第二階段可再搭配傳統的CADD虛擬篩選來縮小候選藥物 (lead)的數量,以提升藥物開發準確性。
二、服務優勢
1. 專屬 AI 平台支援高通量藥物篩選
2. 深厚的藥物設計實務經驗
3. 具備客製化設計與製備能力
三、服務方案*實際交貨期依評估後為準Number of compounds Screening period 19 million 2-3 weeks (business days) 48 million 4-6 weeks (business days) 6 billion 12-16 weeks (business days)
四、客戶提供資訊
1. 蛋白名稱及物種
2. 用於篩選的Compound library
五、到貨規格
項目報告



